Adrian M. Trioli

Intellectual Property - Melbourne, Australia

☰ Navigation
  • Home
  • About Us
  • Attorneys
  • Services
  • Technologies & Industries
  • Insights
  • Contact

Australia: Patent Box – Expansion to Agricultural and Low Emissions Innovations

May 31, 2022 by Adrian Trioli

In its Budget 2022-23, the Australian Government announced major expansions to the proposed ‘Patent Box’ scheme providing concessional tax treatment to eligible income for Australian corporate taxpayers. The Government will now expand the scheme to support innovations in the Australian agricultural sector, specifically: Corporate taxpayers who commercialise their eligible patents linked to agriculture and veterinary […]

Filed Under: Agriculture, Australia, Biotechnology, Intellectual Property, Low Emissions, Medical, Patent, Patents, Pharmaceuticals, Plant Breeder's Rights

Australia: Introduction of Patent Box Tax Concessions for Australian Medical and Biotechnology Innovations

June 1, 2021 by Adrian Trioli

In a boost for Australian-based medical and biotechnology innovators, the Australian Government has announced the introduction of a ‘Patent Box’ scheme in its Budget 2021-2022.  Whilst the Government will consult with industry before finalising the details of the Patent Box, features are expected to address the following: (a) With effect from 1 July 2022, a […]

Filed Under: Australia, Biotechnology, Medical, Patent, Patents, Pharmaceuticals Tagged With: Biotechnology, medical, patentbox, Patents

Australian Patent Case Law Snap Shot

August 7, 2019 by Adrian Trioli

Sequenom, Inc. v Ariosa Diagnostics, Inc. [2019] FCA 1011 (27 June 2019)[1] A recent Federal Court of Australia decision held that methods of medical diagnosis are clearly patentable subject matter in Australia. The Federal Court of Australia has taken the opposite position as compared to the corresponding litigation in the United States of America. [2] The main […]

Filed Under: Biotechnology, Patent, Patents, Pharmaceuticals

Australian Patent Case Law Snap Shot

June 4, 2019 by Adrian Trioli

Mylan Health Pty Ltd (formerly BGP Products Pty Ltd) v Sun Pharma ANZ Pty Ltd (formerly Ranbaxy Australia Pty Ltd) [2019] FCA 28 (22 January 2019) A recent Federal Court of Australia decision held that in order for a party to infringe a Swiss-style claim the alleged infringer must manufacture the medicament with the objective intention to […]

Filed Under: Biotechnology, Infringement, Patent, Patents, Pharmaceuticals

  • LinkedIn
  • Twitter

Phone: +61 3 9415 8568

107 Simpson Street
East Melbourne, Victoria 3002, Australia

© 2023 Adrian M. Trioli. All rights reserved.